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Abstract
Several researchers have described two-part models with patient-specific stochastic processes for analysing longitudinal
semicontinuous data. In theory, such models can offer greater flexibility than the standard two-part model with patient-
specific random effects. However, in practice, the high dimensional integrations involved in the marginal likelihood (i.e.
integrated over the stochastic processes) significantly complicates model fitting. Thus, non-standard computationally
intensive procedures based on simulating the marginal likelihood have so far only been proposed. In this paper, we
describe an efficient method of implementation by demonstrating how the high dimensional integrations involved in the
marginal likelihood can be computed efficiently. Specifically, by using a property of the multivariate normal distribution
and the standard marginal cumulative distribution function identity, we transform the marginal likelihood so that the high
dimensional integrations are contained in the cumulative distribution function of a multivariate normal distribution, which
can then be efficiently evaluated. Hence, maximum likelihood estimation can be used to obtain parameter estimates and
asymptotic standard errors (from the observed information matrix) of model parameters. We describe our proposed
efficient implementation procedure for the standard two-part model parameterisation and when it is of interest to
directly model the overall marginal mean. The methodology is applied on a psoriatic arthritis data set concerning
functional disability.
Keywords
Semicontinuous data, two-part models, overall marginal mean, patient-specific inference, serial correlation, psoriatic
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1 Introduction
Semicontinuous data arise when the outcome is a mixture of true zeros and continuously distributed positive
values.1 Some examples in the literature have included average daily alcohol consumption,1 hospital lengths of
stay2 and medical expenditures.3,4 In these situations, and more generally, it is natural to view the outcome as a
result of two processes, the ﬁrst determines if the outcome is zero, and if not the second determines the positive
value. Two-part models are therefore convenient for the analysis of semicontinuous data and have been used
extensively. Recently, Smith et al.3,4 considered the interesting notion of reparameterising the mean of the positive
values in terms of the overall mean, which is arguably a more justiﬁed target of inference (see Tom et al.5 and the
references therein). We also consider this notion with respect to the overall marginal mean in our framework.
Two-part marginal models and two-part mixed models have both been proposed for the analysis of longitudinal
semicontinuous data. The ﬁrst is motivated by obtaining population-based inference and have been constructed
using generalized estimating equations.6 The second is more convenient when patient-speciﬁc inference
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is of interest and are constructed by incorporating correlated patient-speciﬁc random eﬀects in both parts of the
model.7 This paper focuses on the two-part mixed modelling approach, although considerations are provided on
how population-based inference can be obtained.
In some situations, correlated patient-speciﬁc random eﬀects models will not provide an adequate ﬁt to the
data. This may especially be the case when the lengths of follow-up are relatively long. Here, it may be less
plausible to assume that patients can only have consistently high or low outcomes throughout their entire
follow-up. In terms of the correlation structure, it may not be reasonable to assume constant correlation
between outcomes from the same patient regardless of their gap times (which is induced by patient-speciﬁc
random eﬀects). Flexible two-part models that allow for random changes in the trajectory through serially
correlated stochastic processes may then be more plausible and these have been proposed in the literature.
Albert and Shen8 and Ghosh and Albert9 proposed two-part mixed models that consisted of correlated
Gaussian processes and random walks (in addition to correlated patient-speciﬁc random eﬀects), respectively,
in both parts of the model. Albert and Shen8 demonstrated, through their application and a simulation study, that
overall conditional means may suﬀer from bias if serial correlation (which is not captured by patient-speciﬁc
random eﬀects) is present but ignored. It is also worth noting, both models incorporating stochastic processes
provided considerable improvements of ﬁt to their data.
A main drawback of ﬁtting models with stochastic processes is the computationally intensive nature of the
model ﬁtting procedure. The primary diﬃculty results from the following feature: if a patient has mi observations,
then a model consisting of correlated stochastic processes in each part of the model will require 2mi integrations to
evaluate the marginal likelihood contribution from that patient (assuming, as is usual, the stochastic processes are
realised at the observation times). For manageable values of mi, Albert and Shen
8 and Ghosh and Albert9 have
developed methods based on a Monte Carlo Expectation Maximization algorithm and Markov chain Monte
Carlo, respectively, to evaluate the marginal likelihood. Both of these procedures can be computationally
intensive, with the former also requiring standard errors of parameter estimates to be computed by bootstrap.
The primary aim of this paper is to demonstrate, using a property of the multivariate normal distribution and the
standard marginal cumulative distribution function identity, how a marginal likelihood can be obtained in terms
of the cumulative distribution function of a multivariate normal distribution. Implicitly, because it is possible to
eﬃciently evaluate the cumulative distribution function of a multivariate normal distribution, maximum likelihood
estimation can be used to obtain parameter estimates and (asymptotic) standard errors (from the observed
information matrix) of model parameters.
The rest of this paper is organised as follows. In Section 2, the motivating application concerning functional
disability in psoriatic arthritis is introduced. Section 3 describes the ﬂexible two-part modelling framework of
Albert and Shen8 and Ghosh and Albert9 (including additional comments regarding implementation). Section 4
proposes an eﬃcient maximum likelihood estimation procedure for the models in Section 3. Section 5 applies the
methodology in Section 4 to the data described in Section 2. While retaining the ﬂexibility of using stochastic
processes models and the practicality of the proposed eﬃcient implementation procedure, Section 6 extends the
modelling framework of Section 3 to allow for the direct modelling of the overall marginal mean. Finally,
concluding remarks are made in Section 7.
2 Functional disability in psoriatic arthritis
Psoriatic arthritis (PsA) is an inﬂammatory arthritis associated with the skin condition psoriasis. Because of both
skin and joint involvement of the disease, PsA can result in patients having severe physical functional disability.
The dominant measure of functional disability in PsA, as well as in many other disease areas,10 is the self-reported
health assessment questionnaire (HAQ). This produces an essentially continuous measure1114 between zero,
representing no disability, and three, representing severe disability.
The HAQ scores of 698 patients observed longitudinally at the University of Toronto PsA clinic were
considered for this analysis. Figure 1 shows the frequencies of HAQ scores from these patients. From Figure 1,
it is evident that a large proportion of zeros exist in this data set (1526/4811¼ 0.32). The clumping at zero, together
with the continuous distributed outcomes for the non-zero values, suggests that the HAQ score can be viewed as a
semicontinuous outcome. Su et al.12,13 considered two-part models with patient-speciﬁc random eﬀects for
analysing an earlier version of this PsA data set. In this paper, we relax the assumption of constant patient-
speciﬁc random eﬀects to patient-speciﬁc stochastic processes and consider the extent to which they improve
understanding of the disability process. This includes making easy interpretable inference on the overall
marginal mean HAQ scores, a concept that has not been considered before with stochastic processes models
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(see Section 6 for more details). On average, patients had 6.89 clinic visits (ranging from 2 to 20) with mean inter-
visit and follow-up times of 1 year and 5 months (standard deviation (SD) of 1 year and 1 month) and 8 years and
3 months (SD of 5 years and 10 months), respectively.
3 Model
Let Yij (i ¼ 1, . . . ,N) denote the semicontinuous response from patient i at time tij (j ¼ 1, . . . ,mi), where tij
represents the time of the jth observation from patient i. Because of true zeros, it is natural to decompose the
response into
Uij ¼
1 : Yij4 0
0 : Yij ¼ 0

and gðYijÞjYij4 0, where gðÞ is a monotonic function such that gð0Þ ¼ 0 and gðYijÞjYij4 0 is positive and
approximately Gaussian with constant variance 2. For convenience, the model for Uij is referred to as the
binary component, while the model for gðYijÞjYij4 0 is referred to as the continuous component.
We now describe the ﬂexible modelling framework. Let Xij and Zij be column vectors of covariates that
inﬂuence the probability of Yij> 0 and the mean of gðYijÞjYij4 0, respectively. Then conditional on correlated
patient-speciﬁc random eﬀects ðBri ¼ bri ,Cri ¼ cri Þ and correlated stochastic processes fBsi ðtijÞ ¼ bsij,Csi ðtijÞ ¼ csijg,
where the random eﬀects are assumed independent of the stochastic processes, we model Uij as Bernoulli with
response probability
PðUij ¼ 1jbsij, bri Þ ¼ ðX>ij bþ bsij þ bri Þ ð1Þ
where ðÞ is the cumulative distribution function of a standard Gaussian distribution (i.e. probit model), and
½ gðYijÞjYij4 0; csij, cri  as Gaussian with mean Z>ij cþ csij þ cri and constant variance 2 (i.e. linear mixed eﬀect model
Figure 1. Frequencies of HAQ scores in our data.
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on gðYijÞjYij4 0). Here, b and c are column vectors of regression coeﬃcients. The patient-speciﬁc random eﬀects
ðBri ,Cri Þ allow patients to have a consistently high or low probability of having disability and a consistently high or
low mean for the non-zero HAQ scores across time. While the patient-speciﬁc stochastic processes
fBsi ðti1Þ, . . . , Bsi ðtimiÞ, Csi ðti1Þ, . . . , Csi ðtimiÞg can capture serial correlation and non-predictable changes in
unobserved heterogeneity.9
We assume fBri ,Cri g follows a bivariate normal distribution with mean vector zero and
VarðBri Þ ¼ 2b , VarðCri Þ ¼ 2c , CovðBri ,Cri Þ ¼ bc ð2Þ
where 2b and 
2
c are variance parameters and  is the correlation between B
r
i and C
r
i . Furthermore, we consider two
classes of stochastic processes for fBsi ðtÞ,Csi ðtÞg that are subsequently described. For convenience, deﬁne
BiðtÞ ¼ Bri þ Bsi ðtÞ and CiðtÞ ¼ Cri þ Csi ðtÞ, i.e. the patient-speciﬁc random eﬀects Bri and Cri are absorbed into the
stochastic processes BiðtÞ and CiðtÞ, respectively, and let the covariance matrix of fBiðti1Þ, . . . , BiðtimiÞ,
Ciðti1Þ, . . . , CiðtimiÞg be
Di ¼ Dib DibcDibc Dic
 
:
3.1 Correlated Gaussian processes
The ﬁrst and most general model that we consider is deﬁned when fBsi ðtÞ,Csi ðtÞg are correlated stationary Gaussian
processes. That is the model proposed by Albert and Shen8
CovfBsi ðtijÞ,Bsi ðtikÞg ¼ 2gbjtijtikjgb , CovfCsi ðtijÞ,Csi ðtikÞg ¼ 2gcjtijtikjgc
CovfBsi ðtijÞ,Csi ðtikÞg ¼ gbgcgjtijtikjgbc
ð3Þ
where 2gb and 
2
gc are variance parameters, g is the correlation between the Gaussian processes at the same time
point, and gb, gc, gbc are the degradation parameters governing the serial correlation within and between
processes, respectively. Following Albert and Shen,8 the processes BiðtÞ and CiðtÞ are taken to be exchangeable
Ornstein-Uhlenbeck (EOU) processes, and the model containing these processes is called the general model, i.e.
(1–3). Some special cases of the general model are
. Shared EOU process model when cij ¼ bij,
. Correlated OU processes model when 2b  2c    0,
. Shared OU process model when csij ¼ bsij and 2b  2c    0,
. Correlated random eﬀects model when 2gb  2gc  g  gb  gc  gbc  0,
. Shared random eﬀect model when cri ¼ bri and 2gb  2gc  g  gb  gc  gbc  0,
where  is a parameter to be estimated.
3.1.1 Remarks on gb, gc and gbc
Although the general model is very ﬂexible, it will not always be mathematically valid. Let the covariance matrices
Dsib, D
s
ic and D
s
ibc have (j, k)th entry 
2
gb
jtijtikj
gb , 
2
gc
jtijtikj
gc and gbgcg
jtijtikj
gbc respectively, i.e. described by equation
(3). If gb, gc and gbc are unconstrained (as speciﬁed by Albert and Shen
8), the matrix Dsi where
Dsi ¼
Dsib D
s
ibc
Dsibc D
s
ic
 
will not in general be a valid covariance matrix since Dsi , although symmetric, is not constrained to be positive
semi-deﬁnite and therefore Bsi ðtÞ and Csi ðtÞ will not necessarily form a jointly Gaussian process. The primary
diﬃculty results when g (the correlation between B
s
i ðtÞ and Csi ðtÞ at each time t) is close to one because the
processes Bsi ðtÞ and Csi ðtÞ are similar and therefore it will not be plausible for them to degrade at vastly
diﬀerent rates (i.e. for gb, gc and gbc to be vastly diﬀerent). A reasonable approximation in this situation
would be to constrain the degradation and cross degradation parameters to be same, speciﬁcally
gb  gc  gbc  g1. This constraint would then enforce Dsi to be a valid covariance matrix since the Schur
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component Dsib  DsibcðDsicÞ1Dsibc  2gbð1 2gÞDsi ðg1Þ, where Dsi ðg1Þ has (j, k)th entry jtijtikjg1 , is constrained to be
positive semi-deﬁnite. The resulting correlation structure would then be
CorfBsi ðtijÞ,Bsi ðtikÞg ¼ CorfCsi ðtijÞ,Csi ðtikÞg ¼ jtijtikjg1
CorfBsi ðtijÞ,Csi ðtikÞg ¼ gjtijtikjg1
ð4Þ
In the motivating application, g was estimated close to one. Slight deviations from the correlation structure
described by equation (4) (for example gb  gc  g1 and gbc ¼ g1 where  2 ð0, 1Þ) resulted in non-positive
semi-deﬁnite matrices for various Di, and therefore the model ﬁtting procedure was problematic. Note that a
further simpliﬁcation would be to constrain g ¼ 1 (in addition to g1 ¼ gb), this would result in the shared EOU
process model. If, however, g takes a smaller value, and therefore the two Gaussian processes are less correlated,
it would then be more plausible for the Gaussian processes to degrade at diﬀerent rates. Hence, having
unconstrained degradations parameters will likely be less problematic.
For completeness, note that
fDibgjk ¼ 2b þ 2gbjtijtikjgb
fDicgjk ¼ 2c þ 2gcjtijtikjgc
fDibcgjk ¼ bcþ gbgcgjtijtikjgbc
ð5Þ
3.2 Correlated random walks
The second model structure that we consider is deﬁned when fBsi ðtÞ,Csi ðtÞg are correlated continuous-time random
walks. That is the model proposed by Ghosh and Albert.9 Speciﬁcally, deﬁne sequentially
fBiðtijþ1Þ,Ciðtijþ1ÞgjfBiðtijÞ ¼ bij,CiðtijÞ ¼ cijg to be bivariate normal with mean ðbij, cijÞ and covariance matrix
2wbðtijþ1  tijÞ wbwcwðtijþ1  tijÞ
wbwcwðtijþ1  tijÞ 2wcðtijþ1  tijÞ
 !
In addition ðbi1, ci1Þ ¼ ðbri , cri Þ are initiated at realisations of the patient-speciﬁc random eﬀects. Here, 2wb, 2wc
and w are variance and correlation parameters that quantify serial correlation (both within and across processes).
This model will be denoted by a correlated random walks (CRW) model and it contains as special cases.
. Shared random walk model when cij ¼ bij,
. Correlated random eﬀects model when 2wb  2wc  w  0,
. Shared random eﬀect model when cri ¼ bri and 2wb  2wc  w  0.
Although the CRW model is less ﬂexible than the general model, it has the advantage, from its sequential
construction, of always being well deﬁned even when the parameters are unconstrained (apart from the usual
constraint that correlation parameters have modulus less than or equal to unity). Moreover
fDibgjk ¼ 2b þ 2wbfminðtij, tikÞ  ti1g
fDicgjk ¼ 2c þ 2wcfminðtij, tikÞ  ti1g
fDibcgjk ¼ bcþ wbwcwfminðtij, tikÞ  ti1g
ð6Þ
4 Efficient maximum likelihood estimation procedure for stochastic processes models
This section describes our eﬃcient maximum likelihood estimation procedure for the ﬂexible models described in
Section 3. Firstly, in Section 4.1, we describe a generic likelihood function for all of the described models.
The multivariate normal identity that can be used to evaluate certain multi-dimensional integrals in terms
of a multivariate normal cumulative distribution function is introduced in Section 4.2. Finally, in Section 4.3,
we outline how to apply the multivariate normal identity in Section 4.2 to the generic likelihood function in
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Section 4.1, thus culminating in a computationally eﬃcient likelihood. For completeness, we also provide
computational simpliﬁcations for correlated stochastic processes models in the appendix.
4.1 Likelihoods
For ease of exposition, we describe the likelihood contribution from patient i. The likelihood can then be obtained
by taking the product of all likelihood contributions from each patient. Firstly, we consider models that contain
two (correlated) stochastic processes. For these models, the likelihood contribution from patient i is
Lið?Þ ¼
Z
bi
Z
ci
Ymi
j¼1
ðX>ij bþ bijÞuijf1ðX>ij bþ bijÞg1uij
" #

Ymi
j¼1
1ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
22
p exp ð gð yijÞ  Z
>
ij c cijÞ2
22
( )" #uij" #
ð2miÞðbi, ci; 0,DiÞdbidci
ð7Þ
where ? is a vector comprising all of the unknown parameters, bi ¼ ðbi1, . . . , bimiÞ>,
ci ¼ ðci1, . . . , cimi Þ>, ðmÞð:; l,DÞ is an m dimensional multivariate normal density with mean vector l and
covariance matrix D, and Di is deﬁned by either equation (5) or equation (6). Similarly, for models containing a
single stochastic process (i.e. shared process models), the likelihood contribution from patient i is
Lið?Þ ¼
Z
bi
Ymi
j¼1
ðX>ij bþ bijÞuijf1ðX>ij bþ bijÞg1uij
" #

Ymi
j¼1
1ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
22
p exp ð gð yijÞ  Z
>
ij c bijÞ2
22
( )" #uij" #
ðmiÞðbi; 0,DibÞdbi
ð8Þ
where Dib can again be obtained from equation (5) or equation (6). We now deﬁne our generic likelihood
contribution from patient i which encompasses all of the described models. Throughout we apply the following
notation: 0 and 1 are mi  1 vectors with all entries being zero and one respectively, diagðvÞ is a matrix with
diagonal elements v and zero otherwise, and Id is a d d identity matrix. We also follow the convention that binary
operations with a scalar and vector or matrix argument and unary operations with a vector argument are
performed element-wise. In matrix form, we have
Lið?Þ ¼
Z
li
ðmiÞ Ai1lib þ Ai2li; 0, Imi
  1ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
22
p
 Pmi
j¼1
uij
 exp  ð gðyiÞ  Ai3lic  Ai4liÞ
>ð gðyiÞ  Ai3lic  Ai4liÞ
22
 
fdimðliÞgðli; 0,DilÞdli
ð9Þ
where yi ¼ ð yi1, . . . , yimiÞ>, lib ¼ Xib, lic ¼ Zic, Xi ¼ ðXi1, . . . ,XimiÞ>, Zi ¼ ðZi1, . . . ,ZimiÞ>, and Ai1 ¼
diagð2ui  1Þ, Ai3 ¼ diagðuiÞ are mi mi matrices with ui ¼ ðui1, . . . , uimiÞ>. Here ðd Þð:; 0,DÞ represents the
distribution function of ðd Þð:; 0,DÞ and li is a (to be speciﬁed) column vector of random eﬀects. Note that
equation (9) has resulted from repeated application of the identity 1ðxÞ ¼ ðxÞ.
The likelihood contribution from patient i, Lið?Þ, is then obtained by specifying the vector of random eﬀects li
and its covariance matrix Dil together with the mi  dimðliÞ matrices Ai2 and Ai4 which describe how the random
eﬀects act on the binary and continuous components of the model. For (7), li ¼ ðbi, ciÞ, Ai2 ¼
ðdiagð2ui  1Þ, diagð0ÞÞ and Ai4 ¼ ðdiagð0Þ, diagðuiÞÞ. While for equation (8), li ¼ bi, Ai2 ¼ diagð2ui  1Þ and
Ai4 ¼ diagðuiÞ. Similarly, for the correlated random eﬀects model, li ¼ ðbi, ciÞ, Ai2 ¼ ð2ui  1, 0Þ and
Ai4 ¼ ð0, uiÞ, and for the shared random eﬀect model, li¼ bi, Ai2 ¼ 2ui  1 and Ai4 ¼ ui.
4.2 Multivariate normal identity
In order to evaluate the likelihood described by equation (9), we derive a multivariate normal identity that makes
use of a property of the multivariate normal distribution and the standard marginal cumulative distribution
function identity. Firstly, suppose that x ¼ ðx1,x2Þ> follows a multivariate normal distribution with mean
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vector ð0, gÞ> where x1 and 0 are k1  1 vectors and x2 and g are k2  1 vectors, respectively. Furthermore,
suppose that the covariance matrix of x is the ðk1 þ k2Þ  ðk1 þ k2Þ matrix D where the ﬁrst k1 rows of D is the
k1  ðk1 þ k2Þ matrix ðD22,D>12Þ and the remaining k2 rows of D is the k2  ðk1 þ k2Þ matrix ðD12,D11Þ respectively.
It is a well-known result that ðk1þk2Þðx; ð0, gÞ>,DÞ ¼ ðk1Þðx1;D>12D111 ðx2  gÞ,D22  D>12D111 D12Þðk2Þðx2; g,D11Þ
where the right-hand side is the product of the conditional density of x1jx2 and the marginal density of x2. By
applying the standard marginal cumulative distribution function identity Fx1 ðx1Þ ¼
R
x2
Fx1jx2ðx1jx2Þ fx2 ðx2Þdx2
where the integrand is based on the right-hand side of the above result, we obtain the multivariate normal identity:
ðk1Þðx1; 0,D22Þ ¼
Z
x2
ðk1Þ x1  D>12D111 ðx2  gÞ; 0,D22  D>12D111 D12
 
ðk2Þ x2; g,D11ð Þdx2 ð10Þ
by noting that the marginal distribution of x1 is multivariate normal with mean vector 0 and covariance
matrix 22.
Returning to the application, the general idea is to rearrange equation (9) to take the form of the right-hand side
of equation (10), and then to use equation (10) to compute the integrations over the random eﬀects in terms of an
mi dimensional normal cumulative distribution function. Because there exists eﬃcient implementations of the
multivariate normal cumulative distribution function, this approach will allow for the eﬃcient computation of
the generic likelihood. We note that Barrett et al.15 used equation (10) to obtain computationally eﬃcient
likelihoods of ﬂexible models that jointly consider longitudinal and time to event outcomes. Equation (10) also
arises frequently in results concerning the multivariate skew normal distribution.16–19
4.3 Re-expressing the likelihoods
This section demonstrates how equation (9) (the likelihood contribution from patient i) can be re-expressed. We
ﬁrstly consider the integrand terms resulting from the continuous component and random eﬀects. That is
1ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
22
p
 Pmi
j¼1
uij
exp ð gðyiÞ  Ai3lic  Ai4liÞ
>ð gðyiÞ  Ai3lic  Ai4liÞ
22
 
fdimðliÞgðli; 0,DilÞ ð11Þ
By completing the square in li (see the appendix for more details), equation (11) can be rearranged as
Li1
fdimðliÞgðli; hi,H1i Þ ð12Þ
where
Hi ¼ A>i4Ai4=2 þ ðDilÞ1
hi ¼ H1i A>i4ð gðyiÞ  Ai3licÞ=2
ð13Þ
and
Li1 ¼ 1ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
22
p
 Pmi
j¼1
uij 1
jDilHij1=2
exp  ð gðyiÞ  Ai3licÞ
>ð gðyiÞ  Ai3licÞ
22
þ h
>
i Hihi
2
 
ð14Þ
is independent of li. Substituting equation (12) into equation (9), we consider the integral (ignoring Li1)Z
li
ðmiÞ Ai1lib þ Ai2li; 0, Imi
 
fdimðliÞgðli; hi,H1i Þdli: ð15Þ
We can re-express the argument and covariance matrix of the multivariate normal distribution function in
equation (15) as
Ai1lib þ Ai2li ¼ Ai1lib þ Ai2hi  ðH1i A>i2Þ>Hiðli  hiÞ
Imi ¼ Imi þ Ai2H1i A>i2  ðH1i A>i2Þ>HiðH1i A>i2Þ
ð16Þ
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Therefore equation (15), after applying the multivariate normal identity (described equation (10)), is
equivalent to
ðmiÞ Ai1lib þ Ai2hi; 0, Imi þ Ai2H1i A>i2
  ð17Þ
Based on the above expressions, the likelihood contribution from patient i can now be re-expressed as
Lið?Þ ¼ ðmiÞ Ai1lib þ Ai2hi; 0, Imi þ Ai2H1i A>i2
  1ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
22
p
 Pmi
j¼1
uij
 1jDilHij1=2
exp  ð gðyiÞ  Ai3licÞ
>ð gðyiÞ  Ai3licÞ
22
þ h
>
i Hihi
2
  ð18Þ
where
Ai1 ¼ diagð2ui  1Þ
Ai3 ¼ diagðuiÞ
Hi ¼ A>i4Ai4=2 þ ðDilÞ1
hi ¼ H1i A>i4ð gðyiÞ  Ai3licÞ=2
ð19Þ
and Dil ¼ Di or Dib with Ai2 and Ai4 deﬁned by the speciﬁed model.
From equations (18) and (19), it is now evident that evaluating the integrations involved in Lið?Þ reduces to
computing the cumulative distribution function of a multivariate normal distribution. This can be performed
eﬃciently, for example by using the R20 package mnormt.21 The model ﬁtting procedure is then completed by
maximizing the log-likelihood, for example by using the BFGS22 optimization technique, to obtain parameter
estimates and asymptotic standard errors (from the observed Fisher information matrix) of model parameters.
5 Application: Patient-specific inference
Using the estimation procedure described in Section 4, we demonstrate how patient-speciﬁc inference on the
probability of being disabled and the transformed mean HAQ score conditional on disability can be obtained.
Speciﬁcally, how a unit change in covariate values impacts these quantities for any speciﬁc patient. We consider
the covariate eﬀects of the number of clinically damaged joints (time-dependent), the number of actively inﬂamed
joints (time-dependent), sex (coded as 1 for males and 0 for females), arthritis duration in years (time-dependent),
and age at onset of arthritis in years (standardise). Following Su et al.,12,13 no transformation was applied to the
non-zero HAQ scores, i.e. g(y)¼ y.
Initially, models with two stochastic processes were ﬁtted to the HAQ data. This resulted in large estimated
correlation parameters between the random eﬀects (i.e.   1) and stochastic processes for both the correlated
Gaussian processes and random walks cases (i.e. g and w  1). These results therefore suggested a single
stochastic process would be suﬃcient for describing the data. The shared EOU model was then ﬁtted.
However, the analysis provided evidence for model over-parameterisation as ^2 appeared to converge at
virtually zero and a positive-deﬁnite observed Fisher information matrix could not be attained (even when a
considerably smaller tolerance level than the default was speciﬁed for the computation of multivariate normal
probabilities). We therefore considered the shared random walk and OU process models, and for comparative
purposes, the shared random eﬀect model. The models containing stochastic processes were ﬁtted using the
likelihood described by equations (18) and (19), while the shared random eﬀect model was ﬁtted using
numerical integration (since only a single integration per patient is required). The same parameter estimates for
the shared random eﬀect model were obtained when equations (18) and (19) were used in the model ﬁtting
procedure.
Table 1 presents the results of the ﬁtted models. Across the models, the covariate eﬀects on the mean
conditional on disability are seen to be relatively similar as the conﬁdence intervals generally overlap. In
addition, the models are in agreement with regard to the association of each covariate apart from arthritis
duration. Arthritis duration is statistically signiﬁcant in the shared random eﬀect model but is not statistically
signiﬁcant in the models that incorporate stochastic processes. It is interesting to note that there are strong
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agreements regarding the covariate eﬀect of the number of active joints (similar parameter estimates across models
and relatively narrow conﬁdence intervals). The models indicate an additional actively inﬂamed joint will increase
the mean HAQ score conditional on disability by approximately 0.21 for any speciﬁc patient. For the binary
component, the covariate eﬀects are again seen to be relatively similar due to the overlapping conﬁdence intervals.
Their interpretation through the direction of association and statistical signiﬁcance are also consistent across
models. The covariate eﬀects from the shared random eﬀect model does, however, consistently demonstrate
attenuation to the null when compared to the other models with stochastic processes.
A generalized likelihood ratio test of 2wb ¼ 0 and gb ¼ 1 produced p values of< 0.001 therefore suggesting
preference towards the shared random walk and OU process models respectively when compared to the shared
random eﬀect model. Since the shared random walk and OU process models contain the same number of
parameters, information criteria, such as AIC, would indicate (weakly) that the shared random walk model is
preferable. It is also worth noting that the heterogeneity parameter in the binary component (i.e. 2b or 
2
gb) is
signiﬁcantly lower in the shared random eﬀect model. For this model, this parameter governs both the
heterogeneity and correlation due to repeated measurements and therefore in light of greater unaccounted
heterogeneity (compared to the models with stochastic processes), less correlation is expected.23 In the
continuous component, where 2 also accounts for heterogeneity, a smaller diﬀerence between the
heterogeneity parameters (i.e. 22b or 
22gb) is seen; in the order of the models displayed in the table (from
right to left), the heterogeneity parameters are 0.24, 0.36 and 0.25, respectively.
6 Modelling the overall marginal mean
In many cases, it is of interest to obtain population-based inference in addition/as opposed to patient-speciﬁc
inference. For example, for strategic public health policy purposes, it would be more clinically meaningful to
obtain covariate eﬀects on quantities of interest after averaging over all patients. Currently, the proposed models
are parametrised to allow easily interpretable patient-speciﬁc covariate eﬀects, those with BiðtijÞ ¼ bij
and CiðtijÞ ¼ cij, to act on the patient-speciﬁc mean of the transformed positive values
(i.e. E½ gðYijÞjYij4 0,CiðtijÞ ¼ cij) and the patient-speciﬁc probability of a having a positive value (i.e.
Table 1. Table displaying patient-specific effects and corresponding 95% Wald intervals on the probability of being disabled and the
mean HAQ score conditional on disability.
Shared random walk Shared OU process Shared random effect
Binary component
Damaged joints 0.031 (0.013, 0.049) 0.04 (0.021, 0.059) 0.012 (0.002, 0.022)
Active joints 0.16 (0.13, 0.18) 0.17 (0.15, 0.2) 0.15 (0.13, 0.16)
Sex 1.72 (1.9, 1.54) 2.17 (2.92, 1.42) 1.34 (1.65, 1.02)
Arthritis duration 0.042 (0.025, 0.058) 0.044 (0.022, 0.065) 0.034 (0.023, 0.044)
Age at arthritis onseta 0.56 (0.45, 0.66) 0.68 (0.48, 0.88) 0.45 (0.3, 0.6)
Intercept 1.77 (1.62, 1.92) 1.97 (1.07, 2.87) 1.11 (0.81, 1.41)
Continuous component
Damaged joints 0.0065 (0.0032, 0.0097) 0.0078 (0.0046, 0.011) 0.0033 (0.00086, 0.0058)
Active joints 0.021 (0.019, 0.023) 0.021 (0.019, 0.023) 0.02 (0.018, 0.022)
Sex 0.29 (0.34, 0.24) 0.35 (0.46, 0.23) 0.29 (0.37, 0.21)
Arthritis duration 0.0025 (0.0008, 0.0058) 0.0035 (0.001, 0.0081) 0.0067 (0.0041, 0.0093)
Age at arthritis onseta 0.076 (0.048, 0.1) 0.093 (0.046, 0.14) 0.086 (0.048, 0.12)
Intercept 0.62 (0.57, 0.66) 0.59 (0.44, 0.74) 0.63 (0.56, 0.7)
 0.2 (0.19, 0.22) 0.19 (0.17, 0.21) 0.27 (0.24, 0.3)
2 0.074 (0.069, 0.079) 0.066 (0.06, 0.072) 0.12 (0.11, 0.12)
2b 6.3 (5.64, 7.04) 3.29 (2.64, 4.1)
2gb 10.11 (8.03, 12.74)
2wb 0.58 (0.52, 0.65)
gb 0.95 (0.94, 0.96)
Log-likelihood 3279.08 3282.11 3500.48
aDenotes the standardised version of the covariate.
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PðUij ¼ 1jBiðtijÞ ¼ bijÞ). However, under this parametrisation, it no longer becomes straightforward to obtain
easily interpretable population-level covariate eﬀects on the marginal mean of the transformed positive values
(the mean of the transformed positive values after averaging over all bij and cij, i.e. E½ gðYijÞjYij4 0) since it is a
highly non-linear function of the linear predictors in the binary and continuous components.5 Thus, the eﬀect of a
single covariate is generally interpreted by ﬁxing other covariates at certain values.8 This problem remains even
when population-level covariate eﬀects on the overall marginal mean of the transformed values (i.e. E½ gðYijÞ) are
of primary interest, which has strongly been argued as an important target of inference;24 it is estimated using data
from the same patients over time (unlike E½ gðYijÞjYij4 0) and it is a measure of the undecomposed outcome. We
reiterate that in considering the overall marginal mean of the transformed values as a target of inference, we
assume that the monotonic transformation function is such that gð0Þ ¼ 0 and gðYijÞjYij4 0 is positive and
approximately Gaussian with constant variance 2.
In order to obtain population-based inference on the overall marginal mean of the transformed values, Smith
et al.4 proposed the following model parameterisation
PðUij ¼ 1jBri ¼ bri Þ ¼ g1ðX>ij bþ bri Þ
E½ gðYijÞjCri ¼ cri  ¼ g2ðZ>ij aþ cri Þ
ð20Þ
where g1ðÞ and g2ðÞ are monotonic link functions and Bri ,Cri are, as before, zero mean bivariate normal patient-
speciﬁc random eﬀects. Recall that transformation and link functions diﬀer in that transformation functions are
applied prior to modelling. In their speciﬁc context, Smith et al.4 considered the identity transformation for gðÞ but
allowed the positive values of Yij to follow a log-skew-normal distribution. Under this parametrisation, for a
suitably chosen link function such as g12 being the identity or log link, it is implicit that easily interpretable
covariate eﬀects on the overall marginal mean of gðYijÞ, a, can now be obtained. Smith et al.4 implemented this
model by using a Bayesian estimation approach with
E½ gðYijÞjYij4 0, Bri ¼ bri ,Cri ¼ cri  ¼
g2ðZ>ij aþ cri Þ
g1ðX>ij bþ bri Þ
speciﬁed in the likelihoods deﬁned by equation (7) or equation (8). Note that E½ gðYijÞjYij4 0,Bri ¼ bri ,Cri ¼ cri  is
no longer parametrised to be equivalent to a monotonic function of a linear predictor, as was speciﬁed before.
While this approach for modelling the overall marginal mean is intuitive, it is clear that the multivariate normal
identity in Section 4.2 can no longer be used to compute the integrations over the multi-dimensional random
eﬀects in the marginal likelihood. Thus, as mentioned in the introduction, implementation of such models can be
computationally challenging, especially for our situation where it would be of interest to consider bij and cij (i.e.
realisations of stochastic processes) instead of bri and c
r
i (i.e. realisations of patient-speciﬁc random eﬀects) in
equation (20).
We now propose another method which would allow easily interpretable covariate eﬀects to act on the overall
marginal mean of gðYijÞ. In contrast, this method facilitates the inclusion of stochastic processes because it retains
the proposed eﬃcient implementation procedure described in Section 4. To the best of our knowledge, there are no
other methods in the literature that facilitates the practical implementation of stochastic processes models for
directly modelling the overall marginal mean.
We ﬁrst begin by computing the overall marginal mean of gðYijÞ when
PðUij ¼ 1jBiðtijÞ ¼ bijÞ ¼ g1ðX>ij bþ bijÞ
E½ gðYijÞjYij4 0,CiðtijÞ ¼ cij ¼ ij þ cij
ð21Þ
where ij is a function of covariates (at the jth visit from patient i) and regression coeﬃcients only. That is cij is
now assumed to act additively on the mean of the transformed positive values and not on the overall mean of the
transformed values as is the case in equation (20). For models with two processes, the overall marginal mean of
gðYijÞ is deﬁned by
E½ gðYijÞ ¼
Z
b
Z
c
ðX>ij bþ bijÞðij þ cijÞð2Þðbij, cij; 0,DijÞdbijdcij
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where
Dij ¼
2bij bijcijbcij
bijcijbcij 
2
cij
 !
and 2bij, 
2
cij and bcij are the variances and correlation of BiðtijÞ and CiðtijÞ, respectively. Similarly, the overall
marginal mean for a shared process model is given by
E½ gðYijÞ ¼
Z
b
ðX>ij bþ bijÞðij þ bijÞð1Þðbij; 0, 2bijÞdbij:
Conveniently, these integrals can be computed analytically and this results in

X>ij bﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ 2bij
q
0
B@
1
CAij þ bijcijbcijﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ 2bij
q  X>ij bﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ 2bij
q
0
B@
1
CA
and

X>ij bﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ 2bij
q
0
B@
1
CAij þ 2bijﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ 2bij
q  X>ij bﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ 2bij
q
0
B@
1
CA
respectively. The derivation of the ﬁrst overall marginal mean of gðYijÞ (resulting from models with two processes)
can be found in the supplementary material of Tom et al.,5 and the second overall marginal mean of gðYijÞ is
derived in the appendix. If we specify E½ gðYijÞ ¼ Z>ij a, we can then reparametrise
ij ¼ Z>ij a
bijcijbcijﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ 2bij
q  X>ij bﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ 2bij
q
0
B@
1
CA
2
64
3
75	 X>ij bﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ 2bij
q
0
B@
1
CA ð22Þ
and
ij ¼ Z>ij a
2bijﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ 2bij
q  X>ij bﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ 2bij
q
0
B@
1
CA
2
64
3
75	 X>ij bﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ 2bij
q
0
B@
1
CA
in the respective models. Thus, as in equation (20), a oﬀers easily interpretable covariate eﬀects of Zij on the overall
marginal mean of gðYijÞ (by deﬁnition). In particular, a unit change in components of Zij will increase the overall
marginal mean of gðYijÞ by the respective components in a. However, from equations (21) and (22), it is also
evident that replacing Z>ij c with ij in Section 4 will still allow the proposed eﬃcient estimation procedure to be
applied. It is also possible to reparametrise patient-speciﬁc covariate eﬀects b in the binary component in terms of
population-level covariate eﬀects n, speciﬁcally b ¼ n
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ 2bij
q
, since it can be shown that
PðUij ¼ 1Þ ¼ ðX>ij b=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ 2bij
q
Þ. This relationship is easily proved. In the motivating application, this
reparametrisation led to a numerically unstable optimization routine, therefore ðb, aÞ was estimated with n^
obtained as b^=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ ^2bij
q
and standard errors were calculated using the delta method.
6.1 Population-based inference
Using the parameterisations described in the previous subsection, we demonstrate how population-based inference
on the probability of being disabled and the overall marginal mean HAQ score can be obtained. Speciﬁcally, on
averaging across patients, how a unit change in covariate values impacts these quantities. For illustrative purposes,
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the same covariates as those considered in the patient-speciﬁc case are considered. Note that for generalized linear
models, conditional and marginal covariate eﬀects will generally diﬀer unless certain random eﬀects distributions
and link functions are chosen.25
As mentioned, marginal covariate eﬀects on the probability of being disabled, n, were obtained from
b=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ 2bij
q
with b and 2bij (the variance of BiðtijÞ) estimated using the model ﬁtting procedure. The shared OU
process and random eﬀect models, where 2bij does not depend on j (or i) for these models, were considered. For
models with random walks, 2bij varies with j and therefore n will have a time-dependent interpretation. For
simplicity, these models are not considered. The shared random eﬀect model was ﬁtted using the
parameterisation described by equation (20), with g1ð yÞ ¼ ð yÞ and g2ð yÞ ¼ y, and using the parameterisation
described by equations (21) and (22), thus the same link functions are used and the inferences (at the population-
level) from these models are comparable. These models will be denoted as shared random eﬀect model-overall and
-conditional respectively. Note that unlike at the population-level, the patient-speciﬁc assumptions from the
shared random eﬀect model-overall and -conditional are vastly diﬀerent. The shared random eﬀect-overall
model assumes that the overall patient-speciﬁc mean, i.e. E½YijjBri ¼ bri ,Cri ¼ cri , has a linear form, namely
Z>ij aþ cri . While the shared random eﬀect-conditional model assumes that this quantity takes a particular non-
linear form, namely ðij þ cri ÞðX>ij bþ bri Þ. As before, the shared random eﬀect models (both -overall and -
conditional) were ﬁtted using numerical integration and maximum likelihood estimation under the assumption
that the positive values follow a normal distribution with constant variance.
Table 2 presents the results. Population-level covariate eﬀects on the overall marginal mean are seen to be
relatively similar across models due to the considerable overlap in conﬁdence intervals. All three models are in
strong agreement regarding the population-level covariate eﬀect of the number of active joints. That is, on average,
patients with an additional actively inﬂamed joint have an overall mean HAQ score increased by approximately
0.02. In contrast to the patient-speciﬁc case, the population-level covariate eﬀects on the probability of being
disabled are now more consistent across models. A generalized likelihood ratio test of gb ¼ 1 produced a p value
of< 0.001 and therefore the shared OU process model is to be preferred over the shared random eﬀect-conditional
Table 2. Table displaying population-level effects and corresponding 95% Wald intervals on the probability of being disabled and the
overall marginal mean HAQ score.
Shared OU process Shared random effect-conditional Shared random effect-overall
Binary component
Damaged joints 0.012 (0.006, 0.018) 0.0057 (0.0006, 0.011) 0.0066 (0.002, 0.011)
Active joints 0.05 (0.043, 0.058) 0.063 (0.054, 0.071) 0.051 (0.044, 0.058)
Sex 0.65 (0.88, 0.43) 0.64 (0.8, 0.48) 0.61 (0.76, 0.46)
Arthritis duration 0.013 (0.0057, 0.02) 0.014 (0.0095, 0.02) 0.012 (0.0078, 0.017)
Age at arthritis onseta 0.19 (0.14, 0.24) 0.2 (0.13, 0.27) 0.19 (0.12, 0.26)
Intercept 0.59 (0.35, 0.83) 0.56 (0.42, 0.7) 0.68 (0.55, 0.81)
Overall marginal mean
Damaged Joints 0.0064 (0.0036, 0.0094) 0.0029 (0.00054, 0.0053) 0.004 (0.0016, 0.0065)
Active joints 0.02 (0.018, 0.022) 0.021 (0.019, 0.023) 0.022 (0.02, 0.024)
Sex 0.3 (0.4, 0.19) 0.28 (0.36, 0.21) 0.31 (0.39, 0.23)
Arthritis duration 0.0035 (0.00032, 0.0068) 0.006 (0.0038, 0.0082) 0.0054 (0.0031, 0.0077)
Age at arthritis onseta 0.073 (0.049, 0.098) 0.08 (0.048, 0.11) 0.09 (0.052, 0.13)
Intercept 0.62 (0.5, 0.73) 0.61 (0.54, 0.68) 0.59 (0.52, 0.66)
 0.18 (0.16, 0.2) 0.27 (0.24, 0.29) 0.22 (0.2, 0.24)
2 0.064 (0.057, 0.071) 0.12 (0.11, 0.12) 0.12 (0.11, 0.13)
2b 3.63 (2.92, 4.5) 5.19 (4.26, 6.34)
2gb 11.12 (8.71, 14.19)
gb 0.95 (0.94, 0.96)
Loglikelihood 3277.2 3507.63 3582.78
aDenotes the standardised version of the covariate.
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model. Log-likelihood values also indicate slight preference to the shared random eﬀect-conditional model
(3507.63) over the shared random eﬀect-overall model (3582.78).
7 Discussion
This paper reconsiders the ﬂexible two-part models of Albert and Shen8 and Ghosh and Albert9 and proposes an
eﬃcient method of implementation. Speciﬁcally, the problem of integrating over high dimensional random eﬀects
is replaced by evaluating the cumulative distribution function of a multivariate normal distribution. This leads to
eﬃcient algorithms being employed and results in only an optimization procedure being required for model ﬁtting.
Furthermore, while retaining the ﬂexibility of including stochastic processes and the practicality of an eﬃcient
model ﬁtting procedure, this paper also provides model parameterisations which allow easily interpretable
covariate eﬀects to act on the overall marginal mean. The proposed methodology was applied to a psoriatic
arthritis data set with extensive follow-up information.
Through their application and a simulation study, Albert and Shen8 demonstrated that overall conditional
means (conditional on realisations of stochastic processes) may suﬀer from bias if serial correlation is present but a
shared random eﬀect model is used instead. Furthermore, as the shared random eﬀect model becomes more
misspeciﬁed (gb decreases from one), the degree of bias increases. However, under the same set-up, overall
marginal means were less susceptible to bias. In the motivating application, the estimated degradation
parameters from the shared OU process models were ^gb ¼ 0:95 in both applications (Sections 5 and 6.1). The
reasonably high estimated correlation may therefore explain why the shared random eﬀect model ðgb ¼ 1Þ was a
reasonable approximation in terms of estimating regression coeﬃcients, although it was substantially the worst
ﬁtting model.
Preliminary analyses suggested shared process models were reasonable for our data since ^, ^w and ^g  1 when
the described bivariate processes models were ﬁtted. Although this may not be surprising as both parts of the
model are describing the same response process, it is worth noting that the estimated correlation parameter
(between processes) can in principle take a value between ð1, 1Þ as evidenced in other works.7,9 Our
preliminary analyses also demonstrated the need for careful evaluation of models ﬁtted as problems with over
ﬁtting may arise. This was evident when the estimated random variation parameter was estimated to be virtually
zero (i.e. ^2  0) and the observed Fisher information matrix was non positive-deﬁnite, even when a considerably
smaller tolerance level than the default was speciﬁed for computing multivariate normal probabilities.
As mentioned in Section 6, the proposed model parameterisations were motivated by making inference on the
overall marginal mean. In this regard, covariate eﬀects (both patient-speciﬁc and population-level) on the mean of
the positive values and its correlation structure were assumed not of interest. If the mean of the positive values is of
primary interest, it would be more sensible to directly use equations (18) and (19), as in Section 5, to obtain
patient-speciﬁc eﬀects or derive a similar parameterisation, as in Section 6, to obtain population-level eﬀects.
A limitation of the current framework is that it is based on the assumption gðYijÞjYij4 0 is approximately
Gaussian with constant variance 2. Speciﬁcally, in situations where gðÞ is required to be complex so that this
assumption will at least approximately hold, the resulting inferential targets will no longer be intuitively
interpretable owing to the complexity of the transformation function. One approach that may weaken the need
to assume normality of gðYijÞjYij4 0, particularly when the outcome exhibits a large amount of right skewness
(e.g. medical expenditures), would be to make the alternative assumption gðYijÞjYij4 0 follows a log-normal
distribution. This may allow less complex and hence more interpretable transformation functions to be applied
to the outcome without having to strongly violate the assumption on gðYijÞjYij4 0. Under this alternative
assumption, we provide details in the supplementary materials of how easily interpretable inference on the
overall marginal mean and on the mean of the positive transformed outcomes can be obtained with
computationally eﬃcient likelihoods. Similar techniques to those in the supplementary materials can also be
used when the assumption gðYijÞjYij4 0 follows a log-skew-normal distribution is of interest. Although this
comes at the cost of having an increased number of integrations in the marginal likelihood.
Finally, the model described by equations (18) and (19) with possible simpliﬁcations described in Appendix 2
is very general. Although it was derived in the context of longitudinal semicontinuous data, it contains the
model described by Barrett et al.15 for the longitudinal and survival outcomes setting and implicitly provides a
model for clustered cross-sectional semicontinuous data, where the index (i, j) speciﬁes the jth outcome from the
ith cluster. The multivariate normal identity described in Section 4.2 can also facilitate the ﬁtting of ﬂexible
models describing clustered binary data and continuous bounded outcome data.14 However, it should be noted
that care is required when specifying an appropriate/suitable correlation structure. Particularly, the covariance
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matrix must be constrained to be symmetric and positive semi-deﬁnite otherwise the model ﬁtting procedure will
likely be problematic, as was found here. For these alternative situations, the proposed methodology does
nevertheless oﬀer a strong basis, especially with regard to implementation, for the developing of ﬂexible models.
Acknowledgments
We are grateful to Professor Vernon T. Farewell for providing general discussions on this research. We also acknowledge the
patients in the Toronto Psoriatic Arthritis Clinic.
Declaration of conflicting interests
The author(s) declared no potential conﬂicts of interest with respect to the research, authorship, and/or publication of this
article.
Funding
The author(s) disclosed receipt of the following ﬁnancial support for the research, authorship, and/or publication of this article:
This work was ﬁnancially supported by the UK Medical Research Council [Unit program numbers U105261167 and
MC_UP_1302/3].
References
1. Olsen MK and Schaefer JL. A two-part random effects model for semicontinuous longitudinal data. J Am Stat Assoc 2001;
96: 730–745.
2. Xie H, McHugo G, Sengupta A, et al. A method for analyzing longitudinal outcomes with many zeros. Ment Health Serv
Res 2004; 6: 239–246.
3. Smith VA, Preisser JS, Neelon B, et al. A marginalized two-part model for semicontinuous data. Stat Med 2014; 33:
4891–4930.
4. Smith VA, Neelon B, Preisser JS, et al. A marginalized two-part model for longitudinal semicontinuous data. Stat Meth
Med Res 2015; July: 1–24.
5. Tom BDM, Su L and Farewell VT. A corrected formulation for marginal inference derived from two-part mixed models
for longitudinal semi-continuous data. Stat Methods Med Res 2016; 25: 2014–2020.
6. Hall DB and Zhang Z. Marginal models for zero-inflated clustered data. Stat Model 2004; 4: 161–180.
7. Tooze JA, Grunwald GK and Jones RH. Analysis of repeated measures data with clumping at zero. Stat Meth Med Res
2002; 11: 341–355.
8. Albert PS and Shen J. Modelling longitudinal semicontinuous emesis volume data with serial correlation in an acupuncture
clinical trial. J R Stat Soc: Ser C 2005; 54: 707–720.
9. Ghosh P and Albert PS. A Bayesian analysis for longitudinal semicontinuous data with an application to an acupuncture
clinical trial. Comput Stat Data Anal 2009; 53: 699–706.
10. Bruce B and Fries JF. The Stanford health assessment questionnaire: dimensions and practical applications. Health Qual
Life Outcomes 2003; 1: 1–20.
11. Husted JA, Tom BD, Farewell VT, et al. A longitudinal study of the effect of disease activity and clinical damage on
physical function over the course of psoriatic arthritis: does the effect change over time? Arthritis Rheum 2007; 56: 840–849.
12. Su L, Tom BD and Farewell VT. Bias in two-part mixed models for longitudinal data. Biostatistics 2009; 10: 374–389.
13. Su L, Tom BD and Farewell VT. A likelihood-based two-part marginal model for longitudinal semicontinuous data. Stat
Meth Med Res 2015; 24: 194–205.
14. Hutmacher MM, French JL, Krishnaswami S, et al. Estimating transformations for repeated measures modelling of
continuous bounded outcome data. Stat Med 2010; 30: 935–949.
15. Barrett J, Diggle P, Henderson R and Taylor-Robinson D. Joint modelling of repeated measurements and time-to-event
outcomes: flexible model specification and exact likelihood inference. J R Stat Soc: Ser B 2015; 77: 131–148.
16. Azzalini A. A class of distributions which includes the normal ones. Scand J Stat 1985; 12: 171–178.
17. Azzalini A. The skew-normal distribution and related multivariate families (with discussion). Scand J Stat 1985; 32:
159–200.
18. Arnold BC and Beaver RJ. Hidden truncation models. Sankhya A 2000; 62: 22–35.
19. Arnold BC. Flexible univariate and multivariate models based on hidden truncation. J Stat Plan 2009; 139: 3741–3749.
20. R Development Core Team. R: a language and environment for statistical computing. R Foundation for Statistical
Computing: Vienna, Austria, http://www.R-project.org, ISBN 3-900051-07-0. (accessed 6 May 2017).
14 Statistical Methods in Medical Research 0(0)
21. Azzalini A. mnormt: the multivariate normal and t distributions. R package version 1.5-2, http://azzalini.stat.unipd.it/SW/
Pkg-mnormt (2015).
22. Broyden CG. The convergence of a class of double-rank minimisation algorithms. J Inst Math Appl 1970; 6: 76–90.
23. Henderson R and Shimakura S. A serially correlated gamma frailty model for longitudinal count data. Biometrika 2003;
90: 355–366.
24. Albert PS. Letter to the editor. Biometrics 2005; 47: 879–881.
25. Diggle P, Heagerty P, Liang KY, et al. Analysis of longitudinal data. New York: Oxford University Press, 2002.
26. Owen DB. A table of normal integrals. Commun Stat B Simul 1980; 9: 389–419.
Appendix 1. Rearranging equation (11)
The continuous and random eﬀects component in the integrand of equation (9) is
1ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
22
p
 Pmi
j¼1
uij
exp  ð gðyiÞ  Ai3lic  Ai4liÞ
>ð gðyiÞ  Ai3lic  Ai4liÞ
22
 
fdimðliÞgðli; 0,DilÞ:
We rearrange this expression by completing the square in li. This results in
1ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
22
p
 Pmi
j¼1
uij
exp  ð gðyiÞ  Ai3licÞ
>ð gðyiÞ  Ai3licÞ
22
  jH1i j1=2
jDilj1=2
1
ð2ÞdimðliÞ=2jH1i j1=2
exp  l
>
i Hili
2
þ l>i Hihi
 
: ð23Þ
Focusing on terms containing li, we have
exp  l
>
i Hili
2
þ l>i Hihi
 
¼ exp  ðli  hiÞ
>Hiðli  hiÞ
2
þ h
>
i Hihi
2
 
: ð24Þ
Equations (12) to (14) now follows by substituting equation (24) into equation (23).
Appendix 2. Simplification for correlated stochastic processes model
For the models containing correlated stochastic processes (described by equation (7)), recall that Dil ¼ Di (where Di
is described by either equation (5) or equation (6)), Ai2 ¼ ðdiagð2ui  1Þ, diagð0ÞÞ and Ai4 ¼ ðdiagð0Þ, uiÞ are
mi  2mi matrices. Simpliﬁcation of equation (18) for this model structure is possible, speciﬁcally the following
(to be derived) equations
Ai2hi ¼ Duibc  DuibcðImi þ Duic=2Þ1Duic=2
 ð gðyiÞ  Ai3licÞ=2
Ai2H
1
i A
>
i2 ¼ Duib  DuibcðImi þ Duic=2Þ1Duibc=2
jDiHij ¼ jDicdiagðuiÞ=2 þ Imi j
h>i Hihi ¼ ð gðyiÞ  A3licÞ>ðDuic  DuicðImi þ Duic=2Þ1Duic=2Þð gðyiÞ  Ai3licÞ=4
ð25Þ
where
Duib ¼ diagð2ui  1ÞDibdiagð2ui  1Þ
Duic ¼ diagðuiÞDicdiagðuiÞ
Duibc ¼ diagð2ui  1ÞDibcdiagðuiÞ
reduce the dimension of the respective matrix calculations (from 2mi to mi dimensional).
In order to derive the equations in (25), we begin by simplifying DiHi. That is
DiHi ¼ DiA>i4Ai4=2 þ I2mi ¼
Dib Dibc
Dibc Dic
 
diagð0Þ diagð0Þ
diagð0Þ diagðuiÞ=2
 
þ I2mi
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¼ Imi DibcdiagðuiÞ=
2
diagð0Þ DicdiagðuiÞ=2 þ Imi
 !
:
It now follows that
jDiHij ¼ jImi jjDicdiagðuiÞ=2 þ Imi j ¼ jDicdiagðuiÞ=2 þ Imi j:
Next, we simplify h>i Hihi ¼ ð gðyiÞ  Ai3licÞ>Ai4H1i A>i4ð gðyiÞ  Ai3licÞ=4. By using the Woodbury matrix
identity, speciﬁcally
H1i ¼ Di  DiA>i4ðImi þ Ai4DiA>i4=2Þ1Ai4Di=2
and noting that
Ai4DiA
>
i4 ¼ diagðuiÞDicdiagðuiÞ  Duic
we have
h>i Hihi ¼ ð gðyiÞ  Ai3licÞ>Ai4H1A>i4ð gðyiÞ  Ai3licÞ=4
¼ ð gðyiÞ  Ai3licÞ>ðDuic  DuicðImi þ Duic=2Þ1Duic=2Þð gðyiÞ  Ai3licÞ=4:
To simplify Ai2hi, consider
Ai2hi ¼ Ai2H1i A>i4ð gðyiÞ  Ai3licÞ=2
¼ Ai2DiA>i4  Ai2DiA>i4ðImi þ Duic=2Þ1Duic=2
 ð gðyiÞ  Ai3licÞ=2:
By noting that
Ai2DiA
>
i4 ¼ diagð2ui  1ÞDibcdiagðuiÞ  Duibc
we have
Ai2hi ¼ Duibc  DuibcðImi þ Duic=2Þ1Duic=2
 ð gðyiÞ  Ai3licÞ=2:
Furthermore
Ai2H
1
i A
>
i2 ¼ Duib  DuibcðImi þ Duic=2Þ1Duibc=2
where
Duib  Ai2DiA>i2 ¼ diagð2ui  1ÞDibdiagð2ui  1Þ:
Appendix 3. Overall marginal mean of shared process model
To obtain the overall marginal mean of a shared process model, the following integral must be evaluatedZ
b
ðX>bþ bÞðZ>cþ bÞð1Þðb; 0, 2bÞdb ¼ Z>c
Z
b
ðX>bþ bÞð1Þðb; 0, 2bÞdb
þ 
Z
b
bðX>bþ bÞð1Þðb; 0, 2bÞdb:
ð26Þ
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The ﬁrst term in equation (26) can be evaluated using the skew normal result, i.e. using equation (10), that is
Z>c
Z
b
ðX>bþ bÞð1Þðb; 0, 2bÞdb ¼ Z>cð1ÞðX>b; 0, 1þ 2bÞ ¼ Z>c
X>bﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ 2b
q
0
B@
1
CA:
To compute the second term in equation (26), consider

Z
b
bðX>bþ bÞð1Þðb; 0, 2bÞdb ¼ b
Z
b
bðX>bþ bbÞðbÞdb:
This integral can be computed using equation (10) (011.3) in Owen,26 which results in
2bﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ 2b
q  X>bﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ 2b
q
0
B@
1
CA:
The overall marginal mean now follows.
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